-
Loading metrics
Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach
- Guilherme Silva Julian,
- Ricardo Papaléo Rosim,
- Estela Cristina Carneseca,
- Jéssica Rigolon
x
- Published: March 2, 2020
- https://doi.org/10.1371/journal.pone.0229768